Clinical trial
MR-based Models for Noninvasive Detection of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)
NCT03766880 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MR-based Models for Noninvasive Detection of Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 4, 2018
- Completion date
- April 30, 2019
- Enrollment
- 175 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.